ENY2
Transcription and mRNA export factor ENY2
Also known as: DC6, ENY2_HUMAN, FLJ20480, Sus1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPA8
- Gene
- ENY2
- Ensembl
- ENSG00000120533
- Chromosome
- 8
- Canonical length
- 101 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
Enables transcription coactivator activity. Involved in poly(A)+ mRNA export from nucleus; positive regulation of DNA-templated transcription; and regulation of transcription by RNA polymerase II. Located in mitochondrion and nucleoplasm. Part of SAGA complex and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
101 residues, UniProt reviewed canonical sequence.
>Q9NPA8|ENY2
1 MVVSKMNKDA QMRAAINQKL IETGERERLK ELLRAKLIEC GWKDQLKAHC KEVIKEKGLE
61 HVTVDDLVAE ITPKGRALVP DSVKKELLQR IRTFLAQHAS LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ENY2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 94 nTPM
Expression across tissuesHPA
Tissue
- liver: 94 nTPM
- bone marrow: 83 nTPM
- choroid plexus: 70 nTPM
- kidney: 69 nTPM
- skeletal muscle: 68 nTPM
- tongue: 64 nTPM
Single-cell type
- oocytes: 691 nCPM
- gastric progenitor cells: 491 nCPM
- megakaryocytes: 439 nCPM
- hepatocytes: 423 nCPM
- extravillous trophoblasts: 343 nCPM
- hofbauer cells: 342 nCPM
Immune cell
- non-classical monocyte: 122 nTPM
- intermediate monocyte: 113 nTPM
- classical monocyte: 103 nTPM
- myeloid DC: 94 nTPM
- eosinophil: 94 nTPM
- plasmacytoid DC: 81 nTPM
Brain region
- choroid plexus: 23 nTPM
- hypothalamus: 22 nTPM
- medulla oblongata: 20 nTPM
- white matter: 18 nTPM
- midbrain: 17 nTPM
- pons: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 1.43
- DepMap mean gene effect
- -0.63
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 17% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin organization
- negative regulation of insulin secretion involved in cellular response to glucose stimulus
- poly(A)+ mRNA export from nucleus
- positive regulation of DNA-templated transcription
- protein transport
- regulation of DNA repair
- regulation of RNA splicing
- regulation of transcription by RNA polymerase II
- transcription elongation by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transcription factor, enhancer of yellow 2
- Transcription factor EnY2 superfamily
- Transcription factor e(y)2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ENY2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ENY2 as an antibody target. Whether an autoantibody or antibody against ENY2 could matter depends on whether native ENY2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ENY2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ENY2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...